Company profile
Centillion Technology Limited
Flow Manufacturing Technology by Centillion Tech Ltd
Centillion Technology Limited is a UK company with status active founded in 2017 based in London.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzUzMDI4MDkxNmFkaXF6a2N4
Published 03 Jul 2026 08:21
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQzODM5NjEwNWFkaXF6a2N4
Published 04 Oct 2024 07:42
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzNDI3NDMzMmFkaXF6a2N4
Published 03 Sep 2024 08:33
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Centillion Technology manufactures flow chemistry technology that enables manufacturers to improve productivity and reduce costs.
AI controlled continuous Processing equipment for the food, formulation, biotech and chemicals sectors and related software and services.
Project impact
Organisation established in part as a result of C. Makatsoris' research. Commercialisation of continuous manufacturing technology
Public funding
Projects
SUMMIT – SUstainable Manufacture of Macromolecular Intracellular Therapeutics
1 Feb 2025 to 31 Jan 2027
This project will develop a flexible and scalable RNA-manufacturing process and delivery system for the sustainable manufacture of biologic drugs, with considerably reduced material-use/energy-costs and the need for repurposing or rebuilding facilities. RNA is the medicine platform of the future with many application-types in clinical trial. RNA therapeut...
Supramolecular RNA therapeutics (SMRTs) - developing tunable formulations with scale-independent manufacture.
1 Aug 2023 to 31 Jul 2025
RNA-based medicines and vaccines are of increasing importance to UK national health and wealth. These therapeutics are effective at low dose levels. Different diseases can be treated with different RNAs; but Different RNAs, however, may be made by the same process. The RNA performs its therapeutic task inside a patient's cells: intracellular delivery is c...